Early research (Phase 1)Study completedNCT02234570
What this trial is testing
Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Who this might be right for
Neurocysticercosis
National Institute of Allergy and Infectious Diseases (NIAID) 70